-
Amarin Corporation plc (NASDAQ:AMRN) Q4 2022 Earnings Call Transcript
03 Mar 2023 16:15 GMT
Amarin Corporation plc (NASDAQ:AMRN) Q4 … , 2023
Operator: Welcome to Amarin Corporation’s Conference Call to Discuss … U.S. while facing increasing genetic competition in the U.S … A Session
Follow Amarin Corp Plc (NASDAQ:AMRN) Follow Amarin Corp Plc (NASDAQ:AMRN …
-
Amarin Corporation Plc (AMRN) CEO Karim Mikhail on H.C. Wainwright Global Investment Conference (Transcript)
25 May 2022 23:56 GMT
… Mikhail, President and CEO of Amarin Corporation. For our viewers, Amarin holds … #39;s all about the genetics, and most of these plants … ;re going to have a genetic threat, right? So we … again to Karim and to Amarin Corporation for participating for the update …
-
Amarin Corporation plc (AMRN) CEO Karim Mikhail on Q4 2021 Results - Earnings Call Transcript
01 Mar 2022 15:36 GMT
Amarin Corporation plc (NASDAQ:AMRN) Q4 2021 … SVB Leerink
Operator
Welcome to Amarin Corporation Conference Call to discuss its … the pharmacy level for the genetic.
Having said that, we are …
-
Amarin Corporation plc (AMRN) CEO Karim Mikhail Presents at 40th Annual J.P. Morgan Healthcare Conference (Transcript)
11 Jan 2022 17:32 GMT
Amarin Corporation plc (NASDAQ:AMRN) 40th Annual … terms of the supply of genetics. So if the supply goes …
-
Global Biotech, Pharmaceuticals & Genetics Industry Almanac 2023: Industry Market Research, Statistics, Trends and Leading Companies - ResearchAndMarkets.com
11 Oct 2022 17:30 GMT
… "Biotech, Pharmaceuticals & Genetics Industry Almanac 2023: Biotech, Pharmaceuticals … & Genetics Industry Market Research, Statistics, … PLC
Alnylam Pharmaceuticals Inc
Amarin Corporation plc
Amgen Inc
Amicus …
-
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24
08 Apr 2024 12:00 GMT
… 08, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today highlighted … & Media Inquiries:
Mark Marmur
Amarin Corporation plc
PR@amarincorp.com
Investor … - New insights from epidemiology, genetics, and biology. Circ Res. 2016 …
-
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
06 Apr 2024 19:30 GMT
… 06, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today highlighted … & Media Inquiries:
Mark Marmur
Amarin Corporation plc
PR@amarincorp.com
Investor … - New insights from epidemiology, genetics, and biology. Circ Res. 2016 …
-
Amarin Corporation plc (AMRN) CEO John Thero Presents at H.C. Wainwright 21st Annual Global Investment Conference (Transcript)
09 Sep 2019 17:47 GMT
Amarin Corporation plc (NASDAQ:AMRN) H.C. … years who have looked at genetic markers which have shown that …
-
Amarin Corporation plc (AMRN) CEO John Thero Presents at Goldman Sachs 40th Annual Global Healthcare Conference (Transcript)
13 Jun 2019 02:56 GMT
Amarin Corporation plc (NASDAQ:AMRN) Goldman Sachs … mg/dL. There are genetic studies that show that the …
-
Amarin Corporation plc (AMRN) CEO John Thero Presents at Jefferies 2019 Healthcare Conference (Transcript)
06 Jun 2019 19:23 GMT
Amarin Corporation plc (NASDAQ:AMRN) Jefferies 2019 … results. And we are seeing genetic studies that triglycerides is about …